Multicenter Trial of Prednisone in Alzheimer's Disease - Tabular View

Home

Study Topics

Glossary


	Full Text View


	Tabular View


	Contacts and Locations


	No Study Results Posted


	Related Studies

Multicenter Trial of Prednisone in Alzheimer's Disease

This study has been completed.

Study NCT00000178. Last updated on June 23, 2005. Information provided by National Institute on Aging (NIA)

This Tabular View shows the required WHO registration data elements as marked by ^†

Descriptive Information Fields

Brief Title ^†

Multicenter Trial of Prednisone in Alzheimer's Disease

Official Title ^†

Multicenter Trial of Prednisone in Alzheimer's Disease

Brief Summary

This is a randomized placebo controlled, double blind study. Patients who meet eligibility criteria and decide to participate in the study will be randomly assigned to receive either drug treatment or a placebo. Neither the patients nor the participating investigators will know who is receiving the drugs and who is receiving the placebo. Participation involves 15 outpatient clinic visits over a 68 week period. Patients take study medication at varying doses (the maximum dose is 20 mg daily), along with calcium and vitamin supplements.

Detailed Description

Study Phase

Phase III

Study Type ^†

Interventional

Study Design ^†

Treatment, Randomized, Double-Blind, Placebo Control, Safety/Efficacy Study

Primary Outcome Measure ^†

Secondary Outcome Measure ^†

Condition ^†

Alzheimer Disease

Intervention ^†

Drug: Prednisone

MEDLINE PMIDs

10680787

Links

The Alzheimer's Disease Education and Referral (ADEAR) Center is a service of the National Institute on Aging (NIA). This link exits the ClinicalTrials.gov site

This link exits the ClinicalTrials.gov site

Recruitment Information Fields

Recruitment Status ^†

Completed

Enrollment ^†

Start Date ^†

Completion Date

Eligibility Criteria ^†

Inclusion Criteria:

Patients with Alzheimer's disease who are in stable medical condition

Exclusion Criteria:

Patients with diabetes or severe osteoporosis

Gender

Both

Ages

Accepts Healthy Volunteers

Contacts ^††

Location Countries ^†

United States

Administrative Information Fields

NCT ID ^†

NCT00000178

Organization ID

IA0002

Secondary IDs ^††

3U01AG10483-08S2

Study Sponsor ^†

National Institute on Aging (NIA)

Collaborators ^††

Investigators ^†

Principal Investigator:

Leon Thal, MD.

University of California, San Diego

Information Provided By

National Institute on Aging (NIA)

Verification Date

February 2005

First Received Date ^†

October 29, 1999

Last Updated Date

June 23, 2005

^† Required WHO trial registration data element.
^†† WHO trial registration data element that is required only if it exists.